{"entity":{"type":"insider","cik":"0001515673","url":"/insider/0001515673","json_url":"/insider/0001515673.json","name":"Ultragenyx Pharmaceutical Inc.","name_source":"as-filed","also_issuer":true,"cross_url":"/issuer/0001515673"},"coverage_statement":{"n_transactions":4,"n_filings":2,"first":"2020-12-10","last":"2021-08-12","span_basis":"filed_date"},"name_variants":[{"name":"Ultragenyx Pharmaceutical Inc.","source":"filing","n_filings":2,"first_seen":"2020-12-10","last_seen":"2021-08-12"}],"transactions":[{"id":4142010,"accession":"0001209191-21-051182","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-051182","line_url":"/filing/0001209191-21-051182#line-2","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Arcturus Therapeutics Holdings Inc.","issuer_ticker":"ARCT","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001515673","owner_name":"Ultragenyx Pharmaceutical Inc.","owner_display_name":"Ultragenyx Pharmaceutical Inc.","owner_url":"/insider/0001515673","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75000.0,"shares_display":"75,000","price_per_share":45.83,"price_display":"45.83","price_state":"stated","total_value":3437250.0,"total_display":"3,437,250.00","total_whole":"3,437,250","shares_owned_after":1400000.0,"shares_owned_after_display":"1,400,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-11","filed_date":"2021-08-12","scope":"insider"},{"id":4142006,"accession":"0001209191-21-051182","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-051182","line_url":"/filing/0001209191-21-051182#line-1","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Arcturus Therapeutics Holdings Inc.","issuer_ticker":"ARCT","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001515673","owner_name":"Ultragenyx Pharmaceutical Inc.","owner_display_name":"Ultragenyx Pharmaceutical Inc.","owner_url":"/insider/0001515673","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":725000.0,"shares_display":"725,000","price_per_share":55.44,"price_display":"55.44","price_state":"stated","total_value":40194000.0,"total_display":"40,194,000.00","total_whole":"40,194,000","shares_owned_after":1475000.0,"shares_owned_after_display":"1,475,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-10","filed_date":"2021-08-12","scope":"insider"},{"id":3209660,"accession":"0001209191-20-062733","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-062733","line_url":"/filing/0001209191-20-062733#line-2","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Arcturus Therapeutics Holdings Inc.","issuer_ticker":"ARCT","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001515673","owner_name":"Ultragenyx Pharmaceutical Inc.","owner_display_name":"Ultragenyx Pharmaceutical Inc.","owner_url":"/insider/0001515673","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":357745.0,"shares_display":"357,745","price_per_share":94.97,"price_display":"94.97","price_state":"stated","total_value":33975042.65,"total_display":"33,975,042.65","total_whole":"33,975,043","shares_owned_after":2200000.0,"shares_owned_after_display":"2,200,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-09","filed_date":"2020-12-10","scope":"insider"},{"id":3209652,"accession":"0001209191-20-062733","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-062733","line_url":"/filing/0001209191-20-062733#line-1","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Arcturus Therapeutics Holdings Inc.","issuer_ticker":"ARCT","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001515673","owner_name":"Ultragenyx Pharmaceutical Inc.","owner_display_name":"Ultragenyx Pharmaceutical Inc.","owner_url":"/insider/0001515673","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":442255.0,"shares_display":"442,255","price_per_share":105.54,"price_display":"105.54","price_state":"stated","total_value":46675592.7,"total_display":"46,675,592.70","total_whole":"46,675,593","shares_owned_after":2557745.0,"shares_owned_after_display":"2,557,745","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-08","filed_date":"2020-12-10","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":4,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":4,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":4},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001768224","name":"Arcturus Therapeutics Holdings Inc.","url":"/issuer/0001768224","role":"Director, Ten percent owner","n_filings":2,"first_seen":"2020-12-10","last_seen":"2021-08-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001515673","retrieved_at":"2026-08-25T07:38:01+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}